AAV Vector Shedding Assay—Best Practices in Clinical Gene Therapy Method Development

Practical strategies for overcoming challenges in the development of AAV vectors for gene therapyПодробнее

Solutions for gene therapy using a deeper analytical characterization of AAV vector developmentПодробнее

AAV8 Shedding Assay to Support Gene Therapy Clinical TrialsПодробнее

Automated parallel AAV characterization with new tools for gene therapyПодробнее

Analytical Ultracentrifugation for Characterization of AAV Gene Delivery VectorsПодробнее

Directed Evolution of Next-Generation AAV Vector Systems for Clinical Gene TherapyПодробнее

Federico Mingozzi: Assessing and modulating immune responses to AAV vectors in humansПодробнее

Model Informed Drug Development Approaches for Immunogenicity Assessments WorkshopПодробнее

Pre-clinical AAV production and optimization: Not as easy as it looks! | GenScriptПодробнее

Unlocking the power of AAV and LVV Analytics: Insights and strategies for optimizing viral vector...Подробнее

Droplet Digital PCR as a tool for gene therapy applicationПодробнее

Solutions for Viral Vectors: Enabling Platform Approaches to Advance Cell and Gene TherapiesПодробнее

Improve viral vector development outcomes with high-quality biophysical profiling dataПодробнее

Christine Le Bec - Analytical methods to measure empty and full AAV particlesПодробнее

[Webinar] Advances in gene therapy : next-generation transfection reagent for AAV productionПодробнее

Immunogenicity of AAV Vectors and Transgenes - Roland HerzogПодробнее

Introduction to AAV capsid stability screening using the UncleПодробнее

From Process Development to Manufacturing: Optimize and Scale up the AAV Enrichment StepПодробнее

Frontage Laboratories, Inc. Panel Discussion: Cell and Gene Therapy ft. Weiping Shao, PhDПодробнее